Skip to Main Content

Paper Details

Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden.
Clin Cancer Res
5
2024
Author NameAffiliation
Jonathan W GoldmanDavid Geffen School of Medicine at university of california los angeles
Jonathan W GoldmanDavid Geffen School of Medicine at university of california los angeles
  • 1 - 2

Datasets

Release 1.2